ICO Badalona-H.U. Germans Trias i Pujol
Barcelona 08916
2 studies enrolling now · 2 studies all time
What they study most
KRAS G12C-mutated Solid Tumors, Lung Cancer, KRAS, NRAS, HRAS-mutated NSCLC, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer, Metastatic HER2-positive Breast Cancer, Non-Small Cell Lung Cancer, NSCLC, RAS G12D-mutated NSCLC
Studies at this site
- Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC — Recruiting now
- A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now